Lessons learned from the lessons learned in public health during the first years of COVID-19 pandemic
A Marcassoli, M Leonardi, M Passavanti… - International Journal of …, 2023 - mdpi.com
(1) Objectives: to investigate the main lessons learned from the public health (PH) response
to COVID-19, using the global perspective endorsed by the WHO pillars, and understand …
to COVID-19, using the global perspective endorsed by the WHO pillars, and understand …
Adaptive capacity and preparedness of Clinical and Translational Science Award Program hubs: Overview of an environmental scan
BB Volkov, B Ragon, JM Doyle… - Journal of Clinical and …, 2023 - cambridge.org
The ability of research networks and individual institutions to effectively and efficiently
prepare, respond, and adapt to emergent challenges is essential for the biomedical …
prepare, respond, and adapt to emergent challenges is essential for the biomedical …
Translation in action: Influence, collaboration, and evolution of COVID‐19 research with Clinical and Translational Science Awards consortium support
N Llewellyn, EJ Nehl, G Dave… - Clinical and …, 2024 - Wiley Online Library
Abstract The National Institutes of Health (NIH)'s Clinical and Translational Science Awards
(CTSA) consortium aims to accelerate translational processes that move discoveries from …
(CTSA) consortium aims to accelerate translational processes that move discoveries from …
Improving quality and efficiency of translational research: Environmental scan of adaptive capacity and preparedness of Clinical and Translational Science Award …
RC Shah, V Hoyo, P Moussatche… - Journal of Clinical and …, 2023 - cambridge.org
Translational science is, by definition, groundbreaking; however, without an emphasis on
quality and efficiency, some innovations in healthcare may translate into unnecessary risk …
quality and efficiency, some innovations in healthcare may translate into unnecessary risk …
Leadership and administration to advance translational science: Environmental scan of adaptive capacity and preparedness of Clinical and Translational Science …
COVID-19 reinforced the need for effective leadership and administration within Clinical and
Translational Science Award (CTSA) program hubs in response to a public health crisis. The …
Translational Science Award (CTSA) program hubs in response to a public health crisis. The …
Taking AIM at serious illness: implementing an access to investigational medicines expanded access program
MM Joly, TL Edwards, RN Jerome, A Mainor… - Frontiers in …, 2023 - frontiersin.org
When seriously ill patients have exhausted all treatment options available as part of usual
care, the use of investigational agents may be warranted. Food and Drug Administration's …
care, the use of investigational agents may be warranted. Food and Drug Administration's …
National landscape assessment of academic medical center support for expanded access to investigational products
M Gravelin, JE Adamo, S Ellison, E Segear… - Journal of Clinical and …, 2023 - cambridge.org
Expanded access (EA) provides a pathway for the clinical use of investigational products
(drugs, biologics, and medical devices) for patients who are without satisfactory therapeutic …
(drugs, biologics, and medical devices) for patients who are without satisfactory therapeutic …
Adapting an Expanded Access program to enable investigational treatments for COVID-19
E Samuels, E Champagne, M Gravelin… - Journal of Clinical and …, 2022 - cambridge.org
Retrospective case studies of initiatives supported by the National Institutes of Health's
Clinical and Translational Science Award (CTSA) hubs can be used to identify facilitators …
Clinical and Translational Science Award (CTSA) hubs can be used to identify facilitators …